Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for lung cancer.

Eric M Toloza1, Michael A Morse, H Kim Lyerly

  • 1Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA. toloz001@mc.duke.edu

Journal of Cellular Biochemistry
|June 13, 2006
PubMed
Summary

Lung cancer survival remains low due to late diagnosis and limited treatment options. Gene therapy offers a promising new strategy by targeting the genetic causes of lung cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a STEAP1-Targeted Prostate Cancer Specific Antibody Drug Conjugate Platform with Immunostimulatory Properties.

Research square·2026
Same author

Practical therapeutic options for postoperative chylothorax.

Journal of cardiothoracic surgery·2026
Same author

Manubrial Resection and Reconstruction: Considerations and Operative Techniques.

Thoracic surgery clinics·2026
Same author

Enhanced efficacy of a next-generation EEEV self-replicating RNA platform for combination cancer immunotherapies.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Vector-directed immunity and boosting capacity of VRP-srRNA anti-tumor vaccines.

NPJ vaccines·2026
Same author

Hemodynamics and Mid-Term Clinical Outcomes Following Valve-in-Valve TAVR With Balloon-Expandable Valves.

Circulation. Cardiovascular interventions·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer exhibits a low overall survival rate (15%) despite conventional treatments like chemotherapy, radiation, and surgery.
  • Late diagnosis is a primary reason for poor outcomes, as advanced disease is frequently detected.
  • Current multimodality strategies and platinum-based chemotherapy regimens have reached a therapeutic plateau, necessitating novel approaches.

Purpose of the Study:

  • To explore the therapeutic implications of molecular changes in bronchogenic carcinomas.
  • To review the current status of gene therapy for lung cancer treatment.
  • To highlight the potential of gene therapy in addressing the limitations of conventional lung cancer treatments.

Main Methods:

  • Review of scientific literature on the genetic etiology of lung cancer.
  • Analysis of molecular events in bronchogenic carcinogenesis.
  • Examination of gene transfer techniques in mammalian cells.
  • Discussion of gene therapy strategies, including oncogene blockade and tumor suppressor gene replacement.

Main Results:

  • Understanding the genetic underpinnings of lung cancer is crucial for developing effective therapies.
  • Gene therapy techniques allow for the manipulation of genes involved in cancer development.
  • Potential gene therapy strategies include targeting activated oncogenes and restoring inactivated tumor suppressor genes.

Conclusions:

  • Gene therapy presents a novel and potentially less toxic therapeutic strategy for lung cancer.
  • Targeting specific molecular pathways offers a more precise approach compared to conventional treatments.
  • Further research and clinical application of gene therapy are warranted to improve lung cancer survival rates.

Related Experiment Videos